BCTX ▲ +5.5% - BriaCell Therapeutics Corp. $BCTX BCTXW BCTXZ BCTXL - Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study BriaCell Therapeutics shares rose 5.5% after its Data Safety Monitoring Board recommended continuing the company's Phase 3 trial of its metastatic breast cancer treatment, signaling the independent panel found no safety concerns warranting a halt to the study. The DSMB clearance to proceed is a positive milestone for the trial's advancement toward potential regulatory approval. 14-SEP-2026 07:30 AM ET